- Home
- FNB vs RYTM Comparison
FNB vs RYTM Comparison
Compare FNB & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNB
- RYTM
- Stock Information
- Founded
- FNB 1864
- RYTM 2008
- Country
- FNB United States
- RYTM United States
- Employees
- FNB N/A
- RYTM N/A
- Industry
- FNB Major Banks
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- FNB Finance
- RYTM Health Care
- Exchange
- FNB Nasdaq
- RYTM Nasdaq
- Market Cap
- FNB 5.6B
- RYTM 5.9B
- IPO Year
- FNB N/A
- RYTM 2017
- Fundamental
- Price
- FNB $15.64
- RYTM $86.45
- Analyst Decision
- FNB Strong Buy
- RYTM Strong Buy
- Analyst Count
- FNB 9
- RYTM 13
- Target Price
- FNB $18.33
- RYTM $89.77
- AVG Volume (30 Days)
- FNB 5.2M
- RYTM 1.0M
- Earning Date
- FNB 07-17-2025
- RYTM 08-05-2025
- Dividend Yield
- FNB 3.07%
- RYTM N/A
- EPS Growth
- FNB 8.32
- RYTM N/A
- EPS
- FNB 1.29
- RYTM N/A
- Revenue
- FNB $1,546,029,000.00
- RYTM $136,863,000.00
- Revenue This Year
- FNB $15.18
- RYTM $37.47
- Revenue Next Year
- FNB $10.02
- RYTM $71.16
- P/E Ratio
- FNB $12.14
- RYTM N/A
- Revenue Growth
- FNB 4.25
- RYTM 48.88
- 52 Week Low
- FNB $10.88
- RYTM $40.61
- 52 Week High
- FNB $17.70
- RYTM $94.80
- Technical
- Relative Strength Index (RSI)
- FNB 56.26
- RYTM 66.82
- Support Level
- FNB $15.84
- RYTM $86.25
- Resistance Level
- FNB $16.27
- RYTM $92.14
- Average True Range (ATR)
- FNB 0.37
- RYTM 3.68
- MACD
- FNB -0.06
- RYTM -0.14
- Stochastic Oscillator
- FNB 43.75
- RYTM 72.31
About FNB F.N.B. Corporation
F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.